Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 1 of 1 for:    TRuE-V2
Previous Study | Return to List | Next Study

Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04057573
Recruitment Status : Completed
First Posted : August 15, 2019
Last Update Posted : March 14, 2022
Information provided by (Responsible Party):
Incyte Corporation

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 15, 2021
Actual Study Completion Date : October 1, 2021
Certification/Extension First Submitted : March 8, 2022